Strong room updates


Strong Room appoints seasoned
Healthcare Industry leader Gail Marcus
to Board of Directors


Alternative Text

Gail Marcus is a senior health executive with broad leadership experience across several healthcare sectors in both the US and UK. Named as one of the top 100 women leaders in the state of Massachusetts, she brings a breadth of management, operational and financial knowledge to the Strong Room board and executive team. Ms. Marcus advises start-up organisations through the Martin Trust Center for Entrepreneurship at MIT, the Hofstra Entrepreneurship Center and the Swinburne University Accelerator Program in Australia, where she first met the Strong Room team. She serves on two U.S.- based public company boards, Natera (NTRA) and Triple S (TSM) and two UK-based private company boards (Binx and Cambridge Epigenetics).  

Ms. Marcus transitioned from industry to academia five years ago. She is currently an assistant professor in the Master of Healthcare Administration at Hofstra University.   Previously she was a department chair and assistant professor at Massachusetts College of Pharmacy and Health Sciences, overseeing health care business, regulatory affairs and Pharmacoeconomics programs. Ms. Marcus holds a B.A. from Wesleyan University, a M.B.A in Accounting and Decision Sciences from the Wharton School, a M.S.E in computer science from the University of Pennsylvania and a D.H.A. from the Medical University of South Carolina.

Gail Marcus has commented “It has been rewarding to work with the creative and passionate Strong Room leadership team who are committed to leveraging AI  and technology to improve healthcare.”

Strong Room CEO, Max Mito, commented: “With Strong Room's global ambitions, it's important for us to be able to attract the best calibre individuals to our board. Gail's track record and knowledge is second to none, and is invaluable to the company to lead us onto the next phase of our company. ”

Ms. Marcus's position will be to advise the board on the commercialisation strategy into foreign markets and to assist the executive team to understand the complex remuneration structure of the US healthcare system.